Hsing Chen

1.0k citations

18 papers · 797 indexed · h-index 12

Impact in

Radiology, Nuclear Medicine and Imaging top 2%
- Monoclonal and Polyclonal Antibodies Research
Immunology top 10%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses

Papers in ⓘ

Radiology, Nuclear Medicine and Imaging 13
- Monoclonal and Polyclonal Antibodies Research 13
Immunology 8
- T-cell and B-cell Immunology 6
- Mast cells and histamine 1

Co-authors: Sher Karki (5 shared papers)Greg A. Lazar (5 shared papers)John R. Desjarlais (12 shared papers)Gregory L. Moore (9 shared papers)John O. Richards (2 shared papers)Wei Dang (1 shared paper)Erik Pong (11 shared papers)Seung Y. Chu (10 shared papers)
Journals: Blood (6 papers)mAbs (2 papers)Molecular Cancer Therapeutics (1 paper)Cancer Research (1 paper)Journal of Allergy and Clinical Immunology (1 paper)
Partner nations: United States Taiwan South Korea

In The Last Decade

Hsing Chen

16 papers receiving 746 citations

Peers

Countries citing papers authored by Hsing Chen

Since Specialization

Citations

This map shows the geographic impact of Hsing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hsing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hsing Chen more than expected).

Fields of papers citing papers by Hsing Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hsing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hsing Chen. The network helps show where Hsing Chen may publish in the future.

Co-authors

The 25 scholars most cited alongside Hsing Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hsing Chen Line = papers co-authored together Hsing Chen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells Molecular Cancer Therapeutics ·John O. Richards, Sher Karki, Greg A. Lazar, Hsing Chen, Wei Dang, John R. Desjarlais	2008	235
2	Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions mAbs ·Gregory L. Moore, Hsing Chen, Sher Karki, Greg A. Lazar	2010	193
3	Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody Journal of Allergy and Clinical Immunology ·Seung Y. Chu, Holly M. Horton, Erik Pong, Irene Leung, Hsing Chen, Duc-Hanh T. Nguyen, Cristina Bautista, Umesh S. Muchhal, Matthew J. Bernett, Gregory L. Moore, David E. Szymkowski, John R. Desjarlais	2012	72
4	Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies Blood ·Holly M. Horton, Matthew J. Bernett, Matthias Peipp, Erik Pong, Sher Karki, Seung Y. Chu, John O. Richards, Hsing Chen, Roland Repp, John R. Desjarlais, Eugene A. Zhukovsky	2010	60
5	Suppression of Rheumatoid Arthritis B Cells by XmAb5871, an Anti‐CD19 Antibody That Coengages B Cell Antigen Receptor Complex and Fcγ Receptor IIb Inhibitory Receptor Arthritis & Rheumatology ·Seung Y. Chu, Karen Yeter, Roshan Kotha, Erik Pong, Yvonne Miranda, Sheryl Phung, Hsing Chen, Sung‐Hyung Lee, Irene Leung, Christine Bonzon, John R. Desjarlais, William Stohl, David E. Szymkowski	2013	51
6	Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function Blood ·Yu‐Tzu Tai, Holly M. Horton, Sun‐Young Kong, Erik Pong, Hsing Chen, Sašo Čemerski, Matthew J. Bernett, Duc-Hanh T. Nguyen, Sher Karki, Seung Y. Chu, Greg A. Lazar, Nikhil C. Munshi, John R. Desjarlais, Kenneth C. Anderson, Umesh S. Muchhal	2012	41
7	Engineering Fully Human Monoclonal Antibodies from Murine Variable Regions Journal of Molecular Biology ·Matthew J. Bernett, Sher Karki, Gregory L. Moore, Irene Leung, Hsing Chen, Erik Pong, Duc-Hanh T. Nguyen, Jonathan Jacinto, Jonathan Zalevsky, Umesh S. Muchhal, John R. Desjarlais, Greg A. Lazar	2010	36
8	Immunotherapy with Long-Lived Anti-CD123 × Anti-CD3 Bispecific Antibodies Stimulates Potent T Cell-Mediated Killing of Human AML Cell Lines and of CD123+ Cells in Monkeys: A Potential Therapy for Acute Myelogenous Leukemia Blood ·Seung Y. Chu, Erik Pong, Hsing Chen, Sheryl Phung, Emily Chan, Nancy A. Endo, Rumana Rashid, Christine Bonzon, Irene Leung, Umesh S. Muchhal, Gregory L. Moore, Matthew J. Bernett, David E. Szymkowski, John R. Desjarlais	2014	34
9	Tuning T Cell Affinity Improves Efficacy and Safety of Anti-CD38 × Anti-CD3 Bispecific Antibodies in Monkeys - a Potential Therapy for Multiple Myeloma Blood ·Gregory L. Moore, Sung‐Hyung Lee, Suzanne Schubbert, Yvonne Miranda, Rumana Rashid, Erik Pong, Sheryl Phung, Emily Chan, Hsing Chen, Nancy A. Endo, Maria C. Ardila, Matthew J. Bernett, Seung Y. Chu, Irene Leung, Umesh S. Muchhal, Christine Bonzon, David E. Szymkowski, John R. Desjarlais	2015	23
10	Immune suppression in cynomolgus monkeys by XPro9523 mAbs ·Matthew J. Bernett, Seung Y. Chu, Irene Leung, Gregory L. Moore, Sung‐Hyung Lee, Erik Pong, Hsing Chen, Sheryl Phung, Umesh S. Muchhal, Holly M. Horton, Greg A. Lazar, John R. Desjarlais, David E. Szymkowski	2013	22
11	Immunotherapy with Long-Lived Anti-CD38 × Anti-CD3 Bispecific Antibodies Stimulates Potent T Cell-Mediated Killing of Human Myeloma Cell Lines and CD38+ Cells in Monkeys: A Potential Therapy for Multiple Myeloma Blood ·Seung Y. Chu, Yvonne Miranda, Sheryl Phung, Hsing Chen, Rumana Rashid, Nancy A. Endo, Emily Chan, Erik Pong, Christine Bonzon, Umesh S. Muchhal, Irene Leung, Matthew J. Bernett, Gregory L. Moore, David E. Szymkowski, John R. Desjarlais	2014	14
12	Immunotherapy with Long-Lived Anti-CD20 × Anti-CD3 Bispecific Antibodies Stimulates Potent T Cell-Mediated Killing of Human B Cell Lines and of Circulating and Lymphoid B Cells in Monkeys: A Potential Therapy for B Cell Lymphomas and Leukemias Blood ·Seung Y. Chu, Sung‐Hyung Lee, Rumana Rashid, Hsing Chen, Emily Chan, Sheryl Phung, Erik Pong, Nancy A. Endo, Yvonne Miranda, Christine Bonzon, Irene Leung, Umesh S. Muchhal, Gregory L. Moore, Matthew J. Bernett, David E. Szymkowski, John R. Desjarlais	2014	11
13	Developing and testing a CD with interactive videodisk systems for DM care Hsing Chen	2007	1
14	A comparison of the solid state photochemistry and electron beam chemistry of p-diethylaminobenzaldehyde diphenylhydrazone International Journal of Radiation Applications and Instrumentation Part C Radiation Physics and Chemistry ·J. Pacansky, H. Coufal, R. J. Waltman, Robert J. Cox, Hsing Chen	1987	1
15	District-Wide Evaluation Needs Assessment Study, 1981-82 [and] Appendix Supplement. Richard N. Claus, Hsing Chen	1982	1
16	Plastic-molded package of AlGaInP laser apparatus Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Hsing Chen, Rong‐Yih Hwang, Jung-Tsung Hsu, Biing‐Jye Lee	1996	1
17	Microstructural Characteristics and Shape Memory Effect of Rapidly Quenched Cu-Al-Ni-Cr Alloy MRS Proceedings ·Horng‐Show Koo, Hsing Chen, Fu‐Hsing Chen	1991	1
18	Abstract 5000: Immunotherapy with anti-PSMA x anti-CD3 bispecific antibody stimulates potent killing of a human prostate cancer cell line and target-mediated T cell activation in monkeys: A potential therapy for prostate cancer Cancer Research ·Seung Y. Chu, Erik Pong, Rumana Rashid, Hsing Chen, Emily Chan, Sheryl Phung, Nancy A. Endo, Maria C. Ardila, Christine Bonzon, Irene Leung, Umesh S. Muchhal, Gregory L. Moore, Matthew J. Bernett, John R. Desjarlais, David E. Szymkowski	2016	0

About Hsing Chen

Hsing Chen is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology, Molecular Biology, Genetics and Oncology, having authored 18 papers that have together received 797 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), T-cell and B-cell Immunology (6 papers), Chronic Lymphocytic Leukemia Research (4 papers), CAR-T cell therapy research (3 papers), Glycosylation and Glycoproteins Research (3 papers), Synthesis and Biological Evaluation (2 papers), Semiconductor Quantum Structures and Devices (1 paper) and Mast cells and histamine (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (541 citations), Immunology (415 citations), Oncology (218 citations), Hematology (77 citations) and Genetics (68 citations). Hsing Chen has collaborated with scholars based in United States, Taiwan and South Korea. Frequent co-authors include Sher Karki, Greg A. Lazar, John R. Desjarlais, Gregory L. Moore, John O. Richards, Wei Dang, Erik Pong, Seung Y. Chu, Matthew J. Bernett and Irene Leung. Their work appears in journals such as Blood, mAbs, Molecular Cancer Therapeutics, Cancer Research and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact